NLRP3 and alkaline phosphatase measurement: Supplementation with biochanin A significantly mitigated AP-associated barrier damage by increasing the expression of TJ proteins, decreasing the translocation of E. coli to the pancreas, inhibiting TLR4-MAPK/NF-κB and NLRP3 inflammasome activation, and alleviating AP-associated tissue damage 94.